These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12069175)

  • 21. Multivariate statistics of disposition pharmacokinetic parameters for structurally unrelated drugs used in therapeutics.
    Karalis V; Tsantili-Kakoulidou A; Macheras P
    Pharm Res; 2002 Dec; 19(12):1827-34. PubMed ID: 12523661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans.
    Paxton JW; Kim SN; Whitfield LR
    Cancer Res; 1990 May; 50(9):2692-7. PubMed ID: 2328494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
    Mahmood I
    Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.
    Mahmood I; Balian JD
    Clin Pharmacokinet; 1999 Jan; 36(1):1-11. PubMed ID: 9989339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor.
    Lave T; Saner A; Coassolo P; Brandt R; Schmitt-Hoffmann AH; Chou RC
    J Pharm Pharmacol; 1996 Jun; 48(6):573-7. PubMed ID: 8832489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods.
    Mahmood I; Yuan R
    Biopharm Drug Dispos; 1999 Apr; 20(3):137-44. PubMed ID: 10211866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allometric scaling of marbofloxacin, moxifloxacin, danofloxacin and difloxacin pharmacokinetics: a retrospective analysis.
    Cox SK
    J Vet Pharmacol Ther; 2007 Oct; 30(5):381-6. PubMed ID: 17803728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interspecies allometric meta-analysis of the comparative pharmacokinetics of 85 drugs across veterinary and laboratory animal species.
    Huang Q; Gehring R; Tell LA; Li M; Riviere JE
    J Vet Pharmacol Ther; 2015 Jun; 38(3):214-26. PubMed ID: 25333341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allometric scaling of marbofloxacin pharmacokinetics: a retrospective analysis.
    Yohannes S; Hossain MA; Kim JY; Lee SJ; Kwak DM; Suh JW; Park SC
    Pol J Vet Sci; 2014; 17(1):99-103. PubMed ID: 24724476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of clearance in humans from in vitro human liver microsomes and allometric scaling. A comparative study of the two approaches.
    Mahmood I
    Drug Metabol Drug Interact; 2002; 19(1):49-64. PubMed ID: 12222754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and allometric scaling of levormeloxifene, a selective oestrogen receptor modulator.
    Østerberg O; Kiehr B; Erichsen L; Poulsen HE; Ingwersen SH
    Biopharm Drug Dispos; 2003 Apr; 24(3):121-9. PubMed ID: 12673670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of plasma clearance of 54 extensively metabolized drugs between humans and rats: mean allometric coefficient of 0.66.
    Chiou WL; Robbie G; Chung SM; Wu TC; Ma C
    Pharm Res; 1998 Sep; 15(9):1474-9. PubMed ID: 9755903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Shim HJ; Kim YC; Lee JH; Kwon JW; Kim WB; Kim YG; Kim SH; Lee MG
    Biopharm Drug Dispos; 2005 Oct; 26(7):269-77. PubMed ID: 15991256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.
    Knibbe CA; Zuideveld KP; Aarts LP; Kuks PF; Danhof M
    Br J Clin Pharmacol; 2005 Jun; 59(6):705-11. PubMed ID: 15948935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interspecies scaling: predicting oral clearance in humans.
    Mahmood I
    Am J Ther; 2002; 9(1):35-42. PubMed ID: 11782818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of drug clearance in humans from laboratory animals based on body surface area.
    Liu XD; Chen J
    Eur J Drug Metab Pharmacokinet; 2001; 26(4):249-55. PubMed ID: 11808867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.
    Obach RS; Baxter JG; Liston TE; Silber BM; Jones BC; MacIntyre F; Rance DJ; Wastall P
    J Pharmacol Exp Ther; 1997 Oct; 283(1):46-58. PubMed ID: 9336307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluconazole: interspecies scaling and allometric relationships of pharmacokinetic properties.
    Jezequel SG
    J Pharm Pharmacol; 1994 Mar; 46(3):196-9. PubMed ID: 8027927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals.
    Taverne FJ; van Geijlswijk IM; Heederik DJ; Wagenaar JA; Mouton JW
    BMC Vet Res; 2016 Sep; 12(1):185. PubMed ID: 27596044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.